Community-acquired pneumonia in the elderly.
暂无分享,去创建一个
[1] R. Light,et al. Parapneumonic effusions. , 1980, The American journal of medicine.
[2] J. Bartlett,et al. Community‐Acquired Pneumonia: Impact of Immune Status , 1996, American journal of respiratory and critical care medicine.
[3] A. Fein,et al. Pneumonia in the elderly. Special diagnostic and therapeutic considerations. , 1994, The Medical clinics of North America.
[4] M. Kolczak,et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. , 2000, The New England journal of medicine.
[5] Gilles Clermont,et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. , 2002, American journal of respiratory and critical care medicine.
[6] W. Kapoor,et al. New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.
[7] R. Estruch,et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. , 1997, American journal of respiratory and critical care medicine.
[8] W. Mower,et al. Effect of routine emergency department triage pulse oximetry screening on medical management. , 1995, Chest.
[9] J. Macfarlane,et al. 2004 update of BTS pneumonia guidelines: what’s new? , 2004, Thorax.
[10] M. Leinonen,et al. Chlamydia pneumoniae community-acquired pneumonia: A review of 62 hospitalized adult patients , 1996, Infection.
[11] J. Macfarlane,et al. Early management of younger adults dying of community acquired pneumonia. , 1993, Respiratory medicine.
[12] R. Breiman,et al. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. , 1996, JAMA.
[13] E. Kramarow,et al. Health, United States, 1999; with health and aging chartbook , 1999 .
[14] D. Coakley,et al. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. , 1991, Respiratory medicine.
[15] J. Córdoba-Doña,et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] Thebritishthoracicsocietyrese,et al. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. , 1992, Respiratory medicine.
[17] V L Yu,et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .
[18] P. Mäkelä,et al. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. , 1999, Archives of internal medicine.
[19] T. Marrie,et al. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[20] T. Marrie,et al. Nursing Home‐Acquired Pneumonia: A Case‐Control Study , 1986, Journal of the American Geriatrics Society.
[21] K. Cartwright,et al. Rapid Diagnosis of Bacteremic Pneumococcal Infections in Adults by Using the Binax NOW Streptococcus pneumoniae Urinary Antigen Test: a Prospective, Controlled Clinical Evaluation , 2003, Journal of Clinical Microbiology.
[22] A. Porath,et al. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. , 1996, Respiration; international review of thoracic diseases.
[23] A. Porath,et al. Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. , 1997, Age and ageing.
[24] T. Marrie,et al. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. , 2003, Archives of internal medicine.
[25] C. Berg,et al. Abortion surveillance--United States, 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.
[26] D. Soldo,et al. GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS , 2017 .
[27] V. Yu,et al. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia , 1993, The Lancet.
[28] F. Rodríguez de Castro,et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome , 2004, Thorax.
[29] W. Lim,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.
[30] T. Marrie,et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.
[31] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[32] J. Rello,et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] A. Torres,et al. Viral community-acquired pneumonia in nonimmunocompromised adults. , 2004, Chest.
[34] D. Kaiser,et al. Clinical effectiveness of influenza vaccination in Manitoba. , 1993, JAMA.
[35] M. Fisch,et al. Predicting death in patients hospitalized for community-acquired pneumonia. , 1991, Annals of internal medicine.
[36] S. Kivelä,et al. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. , 1996, Archives of internal medicine.
[37] O. Sacristán,et al. Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity. , 2001, Archives of internal medicine.
[38] M. Elliott,et al. Non-invasive Positive Pressure Ventilation , 1999, Journal of the Royal College of Physicians of London.
[39] E. Ely,et al. Six-month neuropsychological outcome of medical intensive care unit patients , 2003, Critical care medicine.
[40] D. Schwartz,et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] John J. Treanor,et al. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .
[42] M. Niederman,et al. The cost of treating community-acquired pneumonia. , 1998, Clinical therapeutics.
[43] R. Briggs,et al. Raised respiratory rate in elderly patients: a valuable physical sign. , 1982, British medical journal.
[44] Michael J Fine,et al. Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] M. Leinonen,et al. role of serum troponin levels combined with electrocardiographic findings Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines , 2001 .
[46] R. Rodríguez-Roisín,et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.
[47] S. Ewig,et al. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. , 1999, The European respiratory journal.
[48] G. Dinant,et al. The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .
[49] C. Sirio,et al. Long-term mortality and quality of life after prolonged mechanical ventilation* , 2004, Critical care medicine.
[50] I. Bolíbar,et al. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. , 1999, The European respiratory journal.
[51] G. Bernard,et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] J. Macfarlane,et al. HOSPITAL STUDY OF ADULT COMMUNITY-ACQUIRED PNEUMONIA , 1982, The Lancet.
[53] L. Mandell,et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] A. Torres,et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. , 1999, American journal of respiratory and critical care medicine.
[55] Malbea A Lapete,et al. Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .
[56] Leming,et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections , 1997 .
[57] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[58] M. Trabucchi,et al. Is pneumonia still the old man's friend? , 2003, Archives of internal medicine.
[59] Benjamin A Lipsky,et al. Diagnosing pneumonia by physical examination: relevant or relic? , 1999, Archives of internal medicine.
[60] K. Steinberg,et al. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. , 1995, JAMA.
[61] D. Snydman,et al. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. , 1994, Archives of internal medicine.
[62] M. Niederman,et al. Severe community-acquired pneumonia. Assessment of severity criteria. , 1998, American journal of respiratory and critical care medicine.
[63] D. Kaiser,et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.
[64] M. Fine,et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.
[65] D M Fleming,et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. , 1997, The New England journal of medicine.
[66] P. Francioli,et al. Community-Acquired Pneumonia: A Prospective Outpatient Study , 2001, Medicine.
[67] M. Fine,et al. Quality of care, process, and outcomes in elderly patients with pneumonia. , 1997, JAMA.
[68] M. Fine,et al. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia. , 1998, Annals of emergency medicine.
[69] K. Nichol,et al. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. , 1999, Archives of internal medicine.
[70] J. Bartlett,et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. , 2004, Archives of internal medicine.
[71] Y. Ong,et al. Aetiology and outcome of severe community-acquired pneumonia in Singapore. , 1998, The European respiratory journal.
[72] L. Brammer,et al. Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[73] A. Monto,et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. , 2002, The Journal of infectious diseases.
[74] M. Kollef,et al. The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial. , 1998, Chest.
[75] S. Soimakallio,et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. , 1993, American journal of epidemiology.
[76] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[77] E. Manor,et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.
[78] A. Bourdin,et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor , 2004, European Respiratory Journal.
[79] R. Rodríguez-Roisín,et al. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. , 1996, American journal of respiratory and critical care medicine.
[80] A. Monto,et al. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. , 1999, JAMA.
[81] J. de Batlle,et al. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. , 1997, American journal of respiratory and critical care medicine.
[82] M. Leinonen,et al. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. , 1999, Vaccine.
[83] F. Tubau,et al. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. , 2002, The American journal of medicine.
[84] S. Sahn. Management of complicated parapneumonic effusions. , 1993, The American review of respiratory disease.
[85] T. Similowski,et al. Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia , 2000, Annals of Internal Medicine.
[86] M. Cooney,et al. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. , 1979, JAMA.
[87] R. Venezia,et al. Vancomycin and Oxacillin Synergy for Methicillin-Resistant Staphylococci , 2000, Antimicrobial Agents and Chemotherapy.
[88] A. Detsky,et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.
[89] J. Gladman,et al. A hospital study of community acquired pneumonia in the elderly. , 1990, Thorax.
[90] A. Torres,et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. , 1999, American journal of respiratory and critical care medicine.
[91] Introduction to Table V. Premature deaths, monthly mortality, and monthly physician contacts--United States. , 1982, MMWR. Morbidity and mortality weekly report.
[92] Brown Rb. Community-acquired pneumonia: diagnosis and therapy of older adults. , 1993 .
[93] M. Luquin,et al. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain , 1988, European Journal of Clinical Microbiology and Infectious Diseases.
[94] P. Ward,et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. , 2000, JAMA.
[95] M. Woodhead,et al. Aetiology and outcome of severe community-acquired pneumonia. , 1985, The Journal of infection.
[96] J. Rello,et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] I. Suramo,et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[98] N. Cox,et al. Prevention and control of influenza , 1999, The Lancet.
[99] J. Michel,et al. Community‐Acquired Pneumonia in Older Patients , 1996, Journal of the American Geriatrics Society.
[100] M. Niederman,et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. , 2002, Archives of internal medicine.
[101] P. Ward,et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. , 2004, The Journal of infectious diseases.
[102] A. Blainey,et al. Causes of pneumonia presenting to a district general hospital. , 1981, Thorax.
[103] P. Coll,et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. , 1993, The European respiratory journal.
[104] T. Marrie,et al. Epidemiology of community-acquired pneumonia in the elderly. , 1990, Seminars in respiratory infections.
[105] R. Brown. Community-acquired pneumonia: diagnosis and therapy of older adults. , 1993, Geriatrics.
[106] A. El‐Solh,et al. Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. , 2004, Chest.
[107] T. Harrison,et al. Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA. , 2001, Journal of medical microbiology.
[108] G. Clermont,et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. , 2002, American journal of respiratory and critical care medicine.
[109] A. Ma,et al. Predicting bacteremia in patients with community-acquired pneumonia. , 2004, American journal of respiratory and critical care medicine.
[110] B. Harrison,et al. The outcome of community acquired pneumonia treated on the intensive care unit. , 1990, Respiratory medicine.
[111] M. Elliott,et al. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.
[112] S. Ho,et al. Nutritional status of elderly patients during recovery from chest infection and the role of nutritional supplementation assessed by a prospective randomized single-blind trial. , 1994, Age and ageing.
[113] W. Lim,et al. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. , 2001, The European respiratory journal.
[114] T. Marrie,et al. Community‐Acquired Pneumonia Requiring Hospitalization , 1985, Journal of the American Geriatrics Society.
[115] C. Sirio,et al. International comparisons of critical care outcome and resource consumption. , 1997, Critical care clinics.
[116] M. Fine,et al. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. , 1990, The American journal of medicine.
[117] A. Schuchat,et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. , 2000, Archives of internal medicine.
[118] P. Ward,et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. , 1999, JAMA.
[119] J. Guest,et al. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. , 1997, The European respiratory journal.
[120] R. Breiman,et al. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .
[121] J. Macfarlane,et al. Impact of management guidelines on the outcome of severe community acquired pneumonia. , 1997, Thorax.
[122] T. Marrie. Community-acquired pneumonia in the elderly. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] H. Sacks,et al. The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.
[124] Sheldon P Stone,et al. Community-acquired pneumonia , 1998, The Lancet.
[125] T. Marrie,et al. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.
[126] J. A. Cuello,et al. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. , 1990, The American review of respiratory disease.
[127] G. Dinant,et al. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. , 1993, BMJ.
[128] J. R. Parsons,et al. Bacteremia With Streptococcus pneumoniae: Implications for Therapy and Prevention , 1996 .
[129] A J Moskowitz,et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. , 1997, JAMA.
[130] J. Butler. Cigarette smoking and invasive pneumococcal disease , 2000 .
[131] E. Bigler,et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. , 1999, American journal of respiratory and critical care medicine.
[132] K. Nichol,et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.
[133] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[134] J. Macfarlane,et al. PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY , 1987, The Lancet.
[135] B. Lipworth,et al. C-reactive protein. A clinical marker in community-acquired pneumonia. , 1995, Chest.
[136] A. Ortqvist,et al. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. , 1985, Scandinavian journal of infectious diseases.
[137] G. Town,et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. , 1996, Thorax.